| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Brawley Otis W serves as a Director at LYEL and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $1.6M at current prices.
The biggest single holding is A (~$1.6M) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | LYEL Lyell Immunopharma, Inc. | Director | Buy | 35,640 | $0.56 | $19,958.40 | New | -17.8% | +86.4% |